NCT02753985

Adherence to Aromatase Inhibitors: The Role of Partners

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 40 (actual)
• Sponsor: Abramson Cancer Center at Penn Medicine · Academic / Other
• Sex: Female
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

This is a qualitative study which explores the role that partners play in breast cancer survivors adherence to aromatase inhibitors and management of their side effects. Both patients and their partners will be interviewed (separately) in order to capture multiple perspectives. The target number of subjects is 64 (32 patients and 32 partners). The primary method of data collection will be face-to-face semi-structured interviews. These interviews will be audio-recorded.

Conditions

• Breast Cancer Survivors

Interventions

Type	Name	Description
OTHER	Survey

Timeline

• Start date: 2014-07-01
• Primary completion: 2016-04-22
• Completion: 2016-04-22
• First posted: 2016-04-28
• Last updated: 2019-07-23

Locations

1 site across 1 country: United States